Novel extended-release transdermal formulations of the psychedelic N,N-dimethyltryptamine (DMT).
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences August 1, 2024 Christopher G Witowski, Mika R Hess, Nate T Jones et al. 7 citations
There is considerable evidence from the literature that psychedelics, such as N,N-dimethyltryptamine (DMT), are safe and effective treatments for depression. However, clinical administration to induce psychedelic effects and expensive psychotherapy-assisted treatments likely limit accessibility to the average patient. There is emerging evidence that DMT promotes positive behavioral changes in...